chr20-62143844-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_198935.3(SS18L1):c.24C>T(p.Ala8Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000776 in 1,329,180 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0040 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 2 hom. )
Consequence
SS18L1
NM_198935.3 synonymous
NM_198935.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.149
Genes affected
SS18L1 (HGNC:15592): (SS18L1 subunit of BAF chromatin remodeling complex) This gene encodes a calcium-responsive transactivator which is an essential subunit of a neuron-specific chromatin-remodeling complex. The structure of this gene is similar to that of the SS18 gene. Mutations in this gene are involved in amyotrophic lateral sclerosis (ALS). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 20-62143844-C-T is Benign according to our data. Variant chr20-62143844-C-T is described in ClinVar as [Benign]. Clinvar id is 721046.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.149 with no splicing effect.
BS2
High AC in GnomAd4 at 586 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SS18L1 | NM_198935.3 | c.24C>T | p.Ala8Ala | synonymous_variant | 1/11 | ENST00000331758.8 | NP_945173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SS18L1 | ENST00000331758.8 | c.24C>T | p.Ala8Ala | synonymous_variant | 1/11 | 1 | NM_198935.3 | ENSP00000333012.3 | ||
SS18L1 | ENST00000450482 | c.-347C>T | 5_prime_UTR_variant | 1/5 | 5 | ENSP00000398634.1 |
Frequencies
GnomAD3 genomes AF: 0.00395 AC: 586AN: 148208Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
586
AN:
148208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000757 AC: 138AN: 182220Hom.: 1 AF XY: 0.000546 AC XY: 56AN XY: 102634
GnomAD3 exomes
AF:
AC:
138
AN:
182220
Hom.:
AF XY:
AC XY:
56
AN XY:
102634
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000377 AC: 445AN: 1180862Hom.: 2 Cov.: 30 AF XY: 0.000321 AC XY: 188AN XY: 586488
GnomAD4 exome
AF:
AC:
445
AN:
1180862
Hom.:
Cov.:
30
AF XY:
AC XY:
188
AN XY:
586488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00395 AC: 586AN: 148318Hom.: 2 Cov.: 33 AF XY: 0.00373 AC XY: 270AN XY: 72318
GnomAD4 genome
AF:
AC:
586
AN:
148318
Hom.:
Cov.:
33
AF XY:
AC XY:
270
AN XY:
72318
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
SS18L1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 15, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at